On November 20, 2023, ABVC BioPharma Inc (NASDAQ: ABVC) opened at $1.56, higher 9.03% from the last session. During the day, the shares moved up to $1.80 and dropped to $1.53 before settling in for the closing price of $1.55. Price fluctuations for ABVC have ranged from $0.67 to $18.70 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 2020.61% over the past five years. With a float of $4.13 million, this company’s outstanding shares have now reached $7.23 million.
Let’s look at the performance matrix of the company that is accounted for 23 employees. In terms of profitability, gross margin is +68.01, operating margin of -1558.54, and the pretax margin is -1599.80.
ABVC BioPharma Inc (ABVC) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ABVC BioPharma Inc is 42.90%, while institutional ownership is 0.78%.
ABVC BioPharma Inc (ABVC) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 3/30/2023, the company posted -$0.6 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.5) by -$0.1. This company achieved a net margin of -1693.50 while generating a return on equity of -211.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
ABVC BioPharma Inc (NASDAQ: ABVC) Trading Performance Indicators
Check out the current performance indicators for ABVC BioPharma Inc (ABVC). In the past quarter, the stock posted a quick ratio of 0.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.55
Technical Analysis of ABVC BioPharma Inc (ABVC)
ABVC BioPharma Inc (NASDAQ: ABVC) saw its 5-day average volume 5.17 million, a positive change from its year-to-date volume of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 76.88%. Additionally, its Average True Range was 0.23.
During the past 100 days, ABVC BioPharma Inc’s (ABVC) raw stochastic average was set at 16.40%, which indicates a significant decrease from 85.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 125.40% in the past 14 days, which was lower than the 174.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0573, while its 200-day Moving Average is $4.3102. Nevertheless, the first resistance level for the watch stands at $1.8167 in the near term. At $1.9433, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0867. If the price goes on to break the first support level at $1.5467, it is likely to go to the next support level at $1.4033. Assuming the price breaks the second support level, the third support level stands at $1.2767.
ABVC BioPharma Inc (NASDAQ: ABVC) Key Stats
There are currently 3,951K shares outstanding in the company with a market cap of 12.22 million. Presently, the company’s annual sales total 970 K according to its annual income of -16,420 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -2,260 K.